BioNexus Gene Lab
BGLC
BGLC
4 hedge funds and large institutions have $70.7K invested in BioNexus Gene Lab in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HF
HRT Financial
New York
|
+$15K |
| 2 |
VF
Virtu Financial
New York
|
+$14.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.94K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$18.1K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$7.91K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.09K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $33K | +$14.7K | +2,089 | +80% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $16.7K | – | – | – |
|
|
HF
3
HRT Financial
New York
| $15K | +$15K | +2,190 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $5.94K | +$5.94K | +842 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$18.1K | -3,359 | Closed |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$7.91K | -1,492 | Closed |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$3.09K | -583 | Closed |
|